跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
OXACIL CAPSULE 250MG - NPRA Drug Approval Details
Approvals
/
NPRA
/
OXACIL CAPSULE 250MG
Approved
STANDARD
OXACIL CAPSULE 250MG
DUOPHARMA (M) SENDIRIAN BERHAD
🇲🇾 National Pharmaceutical Regulatory Agency
Approval Date
Nov 29, 2025
Approval ID
fb167a456034c53e
Company
DUOPHARMA (M) SENDIRIAN BERHAD
Type
Standard
Approval Details
Approval Id
fb167a456034c53e
Drug Approval Npra Name
OXACIL CAPSULE 250MG
Product Name
OXACIL CAPSULE 250MG
Registration Number
MAL19860041AZ
Holder Company Name
DUOPHARMA (M) SENDIRIAN BERHAD
Holder Address
LOT 2599, JALAN SERULING 59 KAWASAN 3, TAMAN KLANG JAYA 41200 KLANG MALAYSIA
Holder Phone
603-33232759
Manufacturer Company Name
DUOPHARMA (M) SENDIRIAN BERHAD
Manufacturer Address
LOT 2599, JALAN SERULING 59, KAWASAN 3, TAMAN KLANG JAYA, 41200 KLANG MALAYSIA
Source Url
https://quest3plus.bpfk.gov.my/pmo2/detail.php?type=product&id=MAL19860041AZ
Version
1764410688
Active Ingredients
Approved
Quick Info
Agency
NPRA
Country
🇲🇾
Approval Date
Nov 29, 2025
Approval ID
fb167a456034c53e
Type
Standard
Source
Official Source
Back to NPRA Approvals